News
Roche to acquire multiplex molecular diagnostic solutions provider, GenMark Diagnostics for US$ 1.8 billion
Roche and GenMark Diagnostics announced that they have entered into a definitive merger agreement for Roche to fully acquire GenMark at a price of US$ 24.05 per share in an all-cash transaction. This corresponds to a total transaction value...
News
Frost & Sullivan sees decentralization critical to success of Indias Covid-19 vaccination campaign
Union government needs to implement multiple innovative ways to make vaccines easily accessible. decentralization of vaccination is paramount for increasing coverage in urban areas and reach rural India. There is a need to adopt strongly consider moving out of...
News
Biovaxy’s Enters Major Bioproduction Agreement With WuXi Biologics to Synthesize Proteins for Its Sars-CoV-2 Vaccine and Covid-T Immunodiagnostic Programs
BioVaxys Technology Corp., the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement with WuXi Biologics Limited (“WuXi”), a leading global Contract Development and Research Organization...
News
Takeda and IDT Support Manufacturing of Johnson & Johnsons COVID-19 Vaccine
Takeda Pharmaceutical Company Limited announced a mutual agreement with IDT Biologika GmbH, a contract development and manufacturing organization, to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture the single-shot COVID-19 vaccine developed by...
News
Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link
Waters Corporation announced it has entered a reseller agreement with TetraScience, a cloud technology innovator powering transformational changes in life sciences R&D. Through the partnership, Waters will now offer its customers the Empower™ Data Science Link, powered by TetraScience....
News
Elsevier and LexisNexis Collaborate to Increase Access to Patent Information in Pharma and Chemical R&D Workflows
Elsevier, a global leader in research publishing and information analytics, announced a new collaboration with LexisNexis Legal & Professional to strengthen the existing patent coverage in Reaxys®, its information solution for chemistry R&D. This integration gives companies and researchers...
Drug Research
Insilicos Chemistry42 AI system integrated into UCBs drug discovery programs
Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico's Chemistry42™ into UCB's internal drug discovery pipeline. UCB's early adoption of Insilico Medicine's proprietary technology will provide UCB's scientists with the ability to design novel hit...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read